• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ataxins -1、-2、-3和-7形成包涵体。

Inclusion formation by ataxins -1, -2, -3, and -7.

作者信息

Tarlac Volga, Turnbull Victor, Stefani Daniela, Kelly Louise, Walsh Renae, Storey Elsdon

机构信息

Van Cleef Roet Centre for Nervous Diseases, Department of Medicine (Neuroscience), Monash University (Alfred Hospital Campus), Melbourne, VIC, Australia.

出版信息

Int J Neurosci. 2007 Sep;117(9):1289-314. doi: 10.1080/00207450600936668.

DOI:10.1080/00207450600936668
PMID:17654093
Abstract

The authors studied inclusion formation in vitro using transiently transfected PC12 cells, with epitope-tagged and untagged full-length and truncated wild-type and expanded ataxins -1, -2, -3, and -7. At 72 hours, no inclusions were seen with wild-type full-length or truncated ataxins -2, -3, or -7, and only one with ataxin-1. Truncation abolished nuclear localization of ataxins -1 and -7, and allowed nuclear entry of ataxin-2. Of the expanded ataxins, only -1 and -2 formed inclusions, and those of ataxin-2 were rare and exclusively cytoplasmic. Truncation resulted in inclusion formation by ataxins -3 and -7, increased ataxin-1 inclusions, and enabled formation of nuclear ataxin-2 inclusions. There was no recruitment of wild-type ataxin-1 to expanded ataxin-1 inclusions.

摘要

作者使用瞬时转染的PC12细胞在体外研究包涵体形成,所用的蛋白包括带有表位标签和未带标签的全长及截短的野生型和扩展型ataxin -1、-2、-3和-7。72小时时,野生型全长或截短的ataxin -2、-3或-7未观察到包涵体,ataxin-1仅观察到一个。截短消除了ataxin -1和-7的核定位,并使ataxin-2能够进入细胞核。在扩展型ataxins中,只有-1和-2形成包涵体,且ataxin-2的包涵体很少且仅存在于细胞质中。截短导致ataxin -3和-7形成包涵体,增加了ataxin-1包涵体的形成,并使细胞核中形成ataxin-2包涵体。野生型ataxin-1不会被招募到扩展型ataxin-1包涵体中。

相似文献

1
Inclusion formation by ataxins -1, -2, -3, and -7.ataxins -1、-2、-3和-7形成包涵体。
Int J Neurosci. 2007 Sep;117(9):1289-314. doi: 10.1080/00207450600936668.
2
Amino acid sequences flanking polyglutamine stretches influence their potential for aggregate formation.多聚谷氨酰胺延伸段两侧的氨基酸序列会影响其形成聚集体的可能性。
Neuroreport. 2001 Oct 29;12(15):3357-64. doi: 10.1097/00001756-200110290-00042.
3
Progress in pathogenesis studies of spinocerebellar ataxia type 1.1型脊髓小脑共济失调发病机制研究进展
Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1079-81. doi: 10.1098/rstb.1999.0462.
4
Differential effects of polyglutamine proteins on nuclear organization and artificial reporter splicing.聚谷氨酰胺蛋白对细胞核组织和人工报告基因剪接的差异影响。
J Neurosci Res. 2007 Aug 15;85(11):2306-17. doi: 10.1002/jnr.21369.
5
Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease.在神经元核内透明包涵体病中,未扩增的多聚谷氨酰胺蛋白募集至核内聚集体。
J Neuropathol Exp Neurol. 2001 Apr;60(4):369-76. doi: 10.1093/jnen/60.4.369.
6
Dopamine D2 receptor signaling modulates mutant ataxin-1 S776 phosphorylation and aggregation.多巴胺 D2 受体信号调节突变型共济失调蛋白 1 S776 磷酸化和聚集。
J Neurochem. 2010 Aug;114(3):706-16. doi: 10.1111/j.1471-4159.2010.06791.x. Epub 2010 Apr 30.
7
Hereditary ataxias.遗传性共济失调
Mayo Clin Proc. 2000 May;75(5):475-90. doi: 10.4065/75.5.475.
8
Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice.E6-AP泛素连接酶的突变降低了核内包涵体的频率,同时加速了SCA1小鼠中多聚谷氨酰胺诱导的病理变化。
Neuron. 1999 Dec;24(4):879-92. doi: 10.1016/s0896-6273(00)81035-1.
9
Ataxin 1 and ataxin 3 in neuronal intranuclear inclusion disease.神经细胞核内包涵体病中的ataxin 1和ataxin 3
Ann Neurol. 1999 Aug;46(2):271-3. doi: 10.1002/1531-8249(199908)46:2<271::aid-ana21>3.0.co;2-m.
10
Co-chaperone CHIP promotes aggregation of ataxin-1.共伴侣蛋白CHIP促进ataxin-1聚集。
Mol Cell Neurosci. 2007 Jan;34(1):69-79. doi: 10.1016/j.mcn.2006.10.002. Epub 2006 Nov 28.

引用本文的文献

1
Oligonucleotide-based strategies to combat polyglutamine diseases.基于寡核苷酸的多聚谷氨酰胺疾病防治策略。
Nucleic Acids Res. 2014 Jun;42(11):6787-810. doi: 10.1093/nar/gku385. Epub 2014 May 21.
2
Neuropathological staging of spinocerebellar ataxia type 2 by semiquantitative 1C2-positive neuron typing. Nuclear translocation of cytoplasmic 1C2 underlies disease progression of spinocerebellar ataxia type 2.通过半定量1C2阳性神经元分型对2型脊髓小脑共济失调进行神经病理学分期。细胞质1C2的核转位是2型脊髓小脑共济失调疾病进展的基础。
Brain Pathol. 2014 Nov;24(6):599-606. doi: 10.1111/bpa.12146. Epub 2014 May 28.
3
Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives.
脊髓小脑性共济失调 2 型:临床表现、分子机制和治疗展望。
Mol Neurobiol. 2013 Feb;47(1):90-104. doi: 10.1007/s12035-012-8348-8. Epub 2012 Sep 21.